Abstract
AbstractOesophagogastric cancers are amongst the commonest cancers world-wide and this commentary explores the current state of curative management for primary oesophagogastric cancers and highlights the differences in treatment approaches between Eastern and Western countries. This commentary also examines the reasons behind these differences including variations in epidemiology, screening programs, surgical techniques and neoadjuvant/ adjuvant therapy and makes suggestions on future treatment approaches.
Publisher
Springer Science and Business Media LLC